Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about UCBJF Recent news which mentions UCBJF Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial September 24, 2024 Tickers BIIB NEWS UCBJF UCBJY Tags Top Stories Stories That Matter General From Benzinga Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage September 10, 2024 Tickers LBPH NEWS UCBJF UCBJY Tags UCBJY Market News LBPH From Benzinga Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB August 29, 2024 Tickers ARGX JNJ NEWS UCBJF Tags UCBJY Market News Benzinga From Benzinga Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies August 26, 2024 Tickers NEWS UCBJF UCBJY Tags Stories That Matter Briefs News From Benzinga There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target January 02, 2024 Tickers LBPH NEWS UCBJF UCBJY Tags Benzinga UCBJY Analyst Ratings From Benzinga Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst September 28, 2023 Tickers AZN DNTH SNY UCBJF Tags Price Target SNY Briefs From Benzinga Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts August 31, 2023 Tickers MLTX SLRN UCBJF UCBJY Tags Health Care UCBJF Biotech From Benzinga FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults June 27, 2023 Tickers ARGX UCBJF UCBJY Tags Biotech UCBJF News From Benzinga Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path February 14, 2023 Tickers MLTX NVS UCBJF UCBJY Tags Small Cap UCBJF Biotech From Benzinga UCB's Rare Childhood Epilepsy Drug Scores FDA Approval March 28, 2022 Tickers UCBJF UCBJY Tags Health Care General News From Benzinga Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane February 08, 2022 Tickers BIIB UCBJF UCBJY Tags Market News UCBJY Benzinga From Benzinga UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study January 21, 2022 Tickers UCBJF UCBJY Tags Biotech UCBJF Briefs From Benzinga Why Zogenix Flew Higher Before Leveling Off This Week January 21, 2022 Tickers UCBJF ZGNX Tags ZGNX Recent Press Releases UCBJF From Motley Fool UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights January 19, 2022 Tickers UCBJF ZGNX Tags News why it's moving Briefs From Benzinga UCB Gets EU Approval For Bimekizumab In Psoriasis August 25, 2021 Tickers NVS UCBJF UCBJY Tags Psoriasis Health Care UCBJF From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.